Radical hypofractionated VMAT-RA for stage III NSCLC in the elderly: feasibility and toxicity

被引：0
|
作者：
Ascolese, A. M. [1 ]
Franceschini, D. [1 ]
De Rose, F. [1 ]
Cozzi, L. [1 ]
Navarria, P. [1 ]
Tozzi, A. [1 ]
Iftode, C. [1 ]
Villa, E. [1 ]
Franzese, C. [1 ]
Comito, T. [1 ]
D'agostino, G. [1 ]
Tomatis, S. [1 ]
Liardo, L. [1 ]
Scorsetti, M. [1 ]
机构：
[1] Ist Clin Humanitas, Radiotherapy & Radiosurg, Rozzano Milan, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)32693-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1443
引用
收藏
页码：S670 / S670
页数：1
相关论文
共 50 条
  • [1] EXTENDING THE BENEFIT OF HYPOFRACTIONATED SBRT TO STAGE II/III NSCLC: A FEASIBILITY STUDY
    Damen, E.
    Holt, A.
    Lakeman, A.
    Belderbos, J.
    Sonke, J. J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S115 - S116
  • [2] Comparison of toxicity and outcome in stage III NSCLC patients treated with IMRT or VMAT
    Wijsman, R.
    Dankers, F.
    Troost, E. G. C.
    Hoffmann, A. L.
    Bussink, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S317 - S317
  • [3] A Clinical Outcome Comparison of IMRT and VMAT in Stage II and III NSCLC Irradiated with Radical Intent
    Belderbos, J.
    Wolfhagen, N.
    Knegjens, J.
    Van Diessen, J.
    Van Rossum, P.
    Smits, K.
    De Jong, R.
    Kwint, M.
    Clevers, S.
    Haas, R.
    Stam, B.
    Janssen, T.
    Sonke, J. -J.
    De Jong, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S269 - S270
  • [4] Treating elderly patients with stage III NSCLC
    Wisnivesky, Juan P.
    Strauss, Gary M.
    [J]. LANCET ONCOLOGY, 2012, 13 (07): : 650 - 651
  • [5] Hypofractionated VMAT for early stage breast cancer: acute toxicity and cosmesis in 840 patients
    Iftode, C.
    De Rose, F.
    Franceschini, D.
    Fogliata, A.
    Villa, E.
    Ascolese, A. M.
    Navarria, P.
    D'Agostino, G. R.
    Franzese, C.
    Comito, T.
    Tozzi, A.
    Clerici, E.
    Liardo, R. L. E.
    Stravato, A.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S241 - S242
  • [6] Moderately Hypofractionated PET/CT-Based Thoracic Radiotherapy in Elderly and Multimorbid Patients with Stage II/III NSCLC
    Kravutske, H.
    Lehmann, J.
    Guggenberger, J. E.
    Mansoorian, S.
    Taugner, J.
    Kaesmann, L.
    Belka, C.
    Manapov, F.
    Eze, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S575 - S576
  • [7] Radical radiotherapy in stage III NSCLC - why not chemoradiotherapy?
    Smith, Eleanor
    Pickles, Rebecca
    Hassani, Adam
    [J]. LUNG CANCER, 2021, 156 : S63 - S64
  • [8] SOCCAR: Sequential or concurrent chemotherapy and hypofractionated accelerated radiotherapy in inoperable stage III NSCLC
    Maguire, J.
    McMenemin, R.
    O'Rourke, N.
    Peedell, C.
    Snee, M.
    Mcnee, S.
    Kelly, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] SOCCAR: SEQUENTIAL OR CONCURRENT CHEMOTHERAPY AND HYPOFRACTIONATED ACCELERATED RADIOTHERAPY IN INOPERABLE STAGE III NSCLC
    Maguire, Joe
    O'Rourke, Noelle
    Peedell, Clive
    Mcmenemin, Rhona
    Snee, Michael P.
    Mcnee, Stuart
    Kelly, Veronica
    Khan, Iftekhar
    Slade, Rachel
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1561 - S1562
  • [10] The largest UK single centre series using hypofractionated radical radiotherapy for NSCLC in the very elderly
    McPartlin, A. J.
    Chaudhry, S.
    Swindell, R.
    Bayman, N.
    Burt, P.
    Chittalia, A.
    Cootes, J.
    Finn, C. Faivre
    Harris, M.
    Lander, H.
    Lee, L.
    Sheikh, H.
    Pemberton, L.
    [J]. LUNG CANCER, 2013, 81 (01) : 144 - 144
12345